Home › NDC Lookup › RxCUI directory › RxCUI 310437

Galantamine 8 MG Oral Tablet — RxCUI 310437

RxNorm drug concept · Semantic clinical drug
RxCUI 310437 Semantic clinical drug · SCD ● Current RxNorm concept 16 FDA products 22 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310437
Official nameGalantamine 8 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asgalantamine 8 MG (as galantamine hydrobromide 10.253 MG) Oral Tablet; galantamine HBr 8 MG Oral Tablet
FDA products mapped16
Package NDCs mapped22
Reported Medicaid activity (SDUD)3,787 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Galantamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats mild to moderate dementia of the Alzheimer’s type. It helps manage symptoms by boosting a brain chemical involved in memory and thinking. It does not stop the disease fro...
  • The extended-release capsule is taken once a day in the morning, preferably with food. The tablets and oral solution are taken twice a day with morning and evening meals. Drink ple...
  • Nausea is the most common, along with vomiting, diarrhea, dizziness, headache and less appetite. These mostly show up while the dose is going up. Nausea usually lasts about a week...
  • Stop the medicine and call right away if you get a skin rash. Also call for fainting, a very slow heartbeat, seizures, black or bloody stools, or trouble urinating or breathing.
📖 Read our full Galantamine guide →

🕸️ Concept Web — How Galantamine 8 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Galantamine 8 MG Oral Tablet RxCUI 310437

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Galantamine 4637
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Galantamine Oral Tablet 384641
    • Galantamine Oral Product 1163354
    • Galantamine Pill 1163355
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Galantamine 8 MG 330345

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Galantamine 8 MG SCDC · 330345
  • Galantamine Oral Tablet SCDF · 384641
  • Galantamine Oral Product SCDG · 1163354
  • Galantamine Pill SCDG · 1163355

📦 FDA Products & Package NDCs

16 products · 22 package NDCs
22 package NDCs map to RxCUI 310437 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24979-0722-04 60 TABLET, FILM COATED in 1 BOTTLE (24979-722-04) Galantamine Upsher-Smith Laboratories, LLC 2024-03-06
24979-0723-04 60 TABLET, FILM COATED in 1 BOTTLE (24979-723-04) Galantamine Upsher-Smith Laboratories, LLC 2024-03-06
24979-0724-04 60 TABLET, FILM COATED in 1 BOTTLE (24979-724-04) Galantamine Upsher-Smith Laboratories, LLC 2024-03-06
51407-0906-60 60 TABLET, FILM COATED in 1 BOTTLE (51407-906-60) Galantamine Golden State Medical Supply, Inc. 2024-04-15
51407-0907-60 60 TABLET, FILM COATED in 1 BOTTLE (51407-907-60) Galantamine Golden State Medical Supply, Inc. 2024-04-15
51407-0908-60 60 TABLET, FILM COATED in 1 BOTTLE (51407-908-60) Galantamine Golden State Medical Supply, Inc. 2024-04-15
57237-0049-60 60 TABLET, FILM COATED in 1 BOTTLE (57237-049-60) Galantamine Rising Pharma Holdings, Inc. 2011-03-29
57237-0050-60 60 TABLET, FILM COATED in 1 BOTTLE (57237-050-60) Galantamine Rising Pharma Holdings, Inc. 2011-03-29
57237-0051-60 60 TABLET, FILM COATED in 1 BOTTLE (57237-051-60) Galantamine Rising Pharma Holdings, Inc. 2011-03-29
65862-0458-19 10000 TABLET, FILM COATED in 1 BOTTLE (65862-458-19) Galantamine Aurobindo Pharma Limited 2011-03-29
65862-0458-60 60 TABLET, FILM COATED in 1 BOTTLE (65862-458-60) Galantamine Aurobindo Pharma Limited 2011-03-29
65862-0458-99 1000 TABLET, FILM COATED in 1 BOTTLE (65862-458-99) Galantamine Aurobindo Pharma Limited 2011-03-29
65862-0459-60 60 TABLET, FILM COATED in 1 BOTTLE (65862-459-60) Galantamine Aurobindo Pharma Limited 2011-03-29
65862-0459-71 7000 TABLET, FILM COATED in 1 BOTTLE (65862-459-71) Galantamine Aurobindo Pharma Limited 2011-03-29
65862-0459-99 1000 TABLET, FILM COATED in 1 BOTTLE (65862-459-99) Galantamine Aurobindo Pharma Limited 2011-03-29
65862-0460-49 4000 TABLET, FILM COATED in 1 BOTTLE (65862-460-49) Galantamine Aurobindo Pharma Limited 2011-03-29
65862-0460-60 60 TABLET, FILM COATED in 1 BOTTLE (65862-460-60) Galantamine Aurobindo Pharma Limited 2011-03-29
65862-0460-99 1000 TABLET, FILM COATED in 1 BOTTLE (65862-460-99) Galantamine Aurobindo Pharma Limited 2011-03-29
70436-0004-06 60 TABLET, FILM COATED in 1 BOTTLE (70436-004-06) Galantamine Slate Run Pharmaceuticals, LLC 2017-08-02
70436-0005-06 60 TABLET, FILM COATED in 1 BOTTLE (70436-005-06) Galantamine Slate Run Pharmaceuticals, LLC 2017-08-02
70436-0006-06 60 TABLET, FILM COATED in 1 BOTTLE (70436-006-06) Galantamine Slate Run Pharmaceuticals, LLC 2017-08-02
72162-2566-06 60 TABLET, FILM COATED in 1 BOTTLE (72162-2566-6) Galantamine Bryant Ranch Prepack 2025-11-04
Observed labelers: Aurobindo Pharma Limited (9) · Golden State Medical Supply, Inc. (3) · Rising Pharma Holdings, Inc. (3) · Slate Run Pharmaceuticals, LLC (3) · Upsher-Smith Laboratories, LLC (3) · Bryant Ranch Prepack (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.